Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients

Experimental Biology and Medicine

Volumn 238, Issue 7, 2013, Pages 779-786

  Al Essa, Mazen ^a   Dhaunsi, Gursev S ^a   Al Qabandi, Wafa'a ^a   Khan, Islam ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

galactosemia; lymphocytes; NADPH oxidase

Indexed keywords

CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MALONALDEHYDE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GALACTOSEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LYMPHOCYTE; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; SPECTROPHOTOMETRY; WESTERN BLOTTING;

GALACTOSEMIA; LYMPHOCYTES; NADPH OXIDASE;

ANTIOXIDANTS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL SEPARATION; CELLS, CULTURED; CHILD, PRESCHOOL; GALACTOSE; GALACTOSEMIAS; GALACTOSEPHOSPHATES; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; INFANT; LIPID PEROXIDATION; LYMPHOCYTES; MALONDIALDEHYDE; NADPH OXIDASE; NITRITES; PHOSPHOPROTEINS;

EID: 84884170771     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213480692     Document Type: Article

References (38)

1. Bosch AM,Grootenhuis MA,Bakker HD,Heijmans HS,Wijburg FA,Last BF.Living with classical galactosemia, health related quality of life consequences.Pediatrics. 2004;113:e423-8.
2. Segal S.Komrower Lecture. Galactosemia today: the enigma and the challenge.J Inherit Metab Dis. 1998;21:455-71.
3. Landt M,Ritter D,Lai K,Benke PJ,Elsas LJ,Steiner RD.Black children deficient in galactose 1-phosphate uridyltransferase: correlation of activity and immunoreactive protein in erythrocytes and leukocytes.J Pediatr. 1997;130:972-80.
4. Wehrli SL,Reynolds R,Chen J,Yager C,Segal S.Metabolism of 13C galactose by lymphoblasts from patients with galactosemia determined by NMR spectroscopy.Mol Genet Metab. 2002;77:296-303.
5. Lai K,Elsas LJ.Structure-function analysis of a common mutation in blacks with transferase-deficiency galactosemia.Mol Genet Metab. 2001;74: 264-72.
6. Leslie ND.Insights into the pathogenesis of galactosemia.Annu Rev Nutr. 2003;23:59-80.
7. Schulpis KH,Papassotiriou I,Tsakiris S.8-hydroxy-2-desoxyguanosine serum concentrations as a marker of DNA damage in patients with classical galactosemia.Acta Paediatrica. 2006;95:164-9.
8. Banerjee AK,Mandal A,Chanda D,Chakraborti S.Oxidant, antioxidant and physical exercise.Mol Cell Biochem. 2003;253:307-12.
9. Yang H,Zhou L,Wang Z,Roberts LJ 2nd,Lin X,Zhao Y,Guo Z.Over expression of antioxidant enzymes in Apo E-deficient mice suppresses benzo(a)pyrene-accelerated atherosclerosis.Atherosclerosis. 2009;207:51-8.
10. Vilaseca-Buscà MA,Artuch-Iriberri R,Colome-Mallolas C,Brandi-Tarrau N,Campistol J,Pineda-Marfá M,Sierra-March C.Abnormal antioxidant system in inborn errors of intermediary metabolism.Rev Neurol. 2002;34:1021-4.
11. Ellis NA,Sengupta N,Caballero S,Guthrie SM,Mames RN,Grant MB.Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia.Antioxid Redox Signal. 2005;7:1413-22.
12. DeLeo FR,Quinn MT.Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins.J Leukoc Biol. 1996;60:677-89.
13. Quinn MT,Ammons MC,Deleo FR.The expanding role of NADPH oxidases in health and disease: no longer just agents for death and destruction.Clin Sci. 2006;111:1-20.
14. Griendling KK,Sorescu D,Ushio-Fukai M.NAD(P)H oxidase: role in cardiovascular biology and disease.Circ Res. 2000;86:494-501.
15. Sorescu D,Szocs K,Griendling KK.NADP(H) oxidases and their relevance to atherosclerosis.Trends Cardiovasc Med. 2001;11:124-31.
16. Kobayashi RH,Kettelhut BV,Kobayashi AL.Galactose inhibition of neonatal neutrophil function.Pediatr Infect Dis. 1983;2:442-5.
17. Barr PH.Association of Escherichia coli sepsis and galactosemia in neonates.J Am Board Fam Pract. 1992;5:89-91.
18. Haller D,Blum S,Bode C,Hammes WP,Schiffren EJ.Activation of human peripheral blood mononuclear cells by non-pathogenic bacteria in vitro: evidence of NK cells as primary targets.Infect Immun. 2000;68:752-9.
19. Yamaguchi A,Fukushi M,Mizushima Y,Shimizu Y,Takasugi N,Arashima S,Ohyanagi K.Microassay for screening newborns for galactosemia with use of a fluorometric microplate reader.Clin Chem. 1989;35:1962-4.
20. Baudhuin P,Beaufay Y,Rahman Y,Sellinger OZ,Wattiaux R,Jacques P,De Duve C.Tissue fractionation studies.Biochem J. 1964;92:179-84.
21. Reddy CC,Tu C,Burgess JR,Ho CY,Scholz RW,Massaro EJ.Evidence for the occurrence of selenium-independent glutathione peroxidase activity in rat liver microsomes.Biochem Biophys Res Commun. 1981;101:970-8.
22. Crapo JD,McCord JM,Fridovich I.Preparation and assay of superoxide dismutases.Methods Enzymol. 1978;53:382-93.
23. Rajagopalan S,Kurz S,Münzel T,Tarpey M,Freeman BA,Griendling K.Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.J Clin Invest. 1996;97:1916-23.
24. Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. 3rd edn. Grune and Stratton, New York, NY: 1984:68-71.
25. Furchgott RF,Zawadzki JV.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature. 1980;288:373-6.
26. Shurin SB.Escherichia coli septicemia in neonates with galactosemia.N Engl J Med. 1977;297:1403-4.
27. Chung MA.Galactosemia in infancy: diagnosis, management and prognosis.Pediatr Nurs. 1997;23:563-9.
28. Widhalm K,Miranda da Cruz BD,Koch M.Diet does not ensure normal development in galactosemia.J Am Coll Nutr. 1997;16:190-1.
29. Gityzelman R.Galactose-1-phosphate in the pathophysiology of galactosemia.Eur J Paediatr. 1995;154:S45-9.
30. Otsyula M,King MS,Ketcham TG,Sanders RA,Watkins JB.Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia.Int J Toxicol. 2003;22:423-7.
31. Kowluru RA,Kern TS,Engerman R.Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.Free Radic Biol Med. 1997;22:587-92.
32. Block K,Gorin Y,Abboud HE.Subcellular localization of Nox4 and regulation in diabetes.Proc Natl Acad Sci USA. 2009;106:14385-90.
33. Matsushima S,Kinugawa S,Yokota T,Inoue N,Ohta Y,Hamaguchi S,Tsutsui H.Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes.Am J Physiol Heart Circ Physiol. 2009;297:H409-16.
34. Ning C,Segal S.Plasma galactose and galactitol concentration in patient with galactose-1-phosphate uridyltransferase deficiency galactosemia: determination by gas chromatography/mass spectrometry.Metabolism. 2000;49:1460-6.
35. Delbosc S,Cristol JP,Descomps B,Chenard J,Sirois P.Oxygen and superoxide anion. Modulation of NADPH oxidase?.J Soc Biol. 2001;195:401-11.
36. Droge W.Free radicals in the physiological control of cell function.Physiol Rev. 2002;82:47-95.
37. Arruda MA,Barja-Fidalgo C.NADPH oxidase activity: in the crossroad of neutrophil life and death.Front Biosci. 2009;14:4546-56.
38. Dale DC,Boxer L,Liles WC.The phagocytes: neutrophils and monocytes.Blood. 2008;112:935-45.